Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
At Hospital/Institution:  Natalie Warren Bryant Cancer Center at St. Francis Hospital
Results 1-25 of 5002 for your search:
Start Over
Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Status: Active
Phase: Phase IV
Type: Treatment
Age: 17 and under
Trial IDs: CDR0000667369, NCI-2014-02026, EU-21011, EUDRACT-2007-004092-19, EURONET-PHL-LP1, NCT01088750
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, B1771007, NCT01180049
Transurethral Resection of Bladder Tumors Using PK Button Vaporization Electrode or Monopolar Loop Electrocautery in Treating Patients with Bladder Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 to 89
Trial IDs: WCI2119-11, NCI-2013-00065, IRB00053735, NCT01567462
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Status: Active
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: GO28399, NCI-2013-01160, 2012-003144-80, NCT01739764
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CDM00047339, NCI-2016-00348, E7059, NCT01774019
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Active
Phase: Phase IV
Type: Treatment
Age: Any age
Trial IDs: CRAD001C2X01B, NCI-2013-01151, NCT01789281
Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer and Hepatitis C Infection
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-213, NCI-2013-01103, NCT01849588
Cancer Venous Thromboembolism (VTE)
Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: DU176b-D-U311, NCI-2015-01358, 2014-004708-30, NCT02073682
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: 16913, NCI-2014-02038, NCT02141438
Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit
Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849
Light Sedation or Intubated General Anesthesia in Reducing Complications and Length of Hospital Stay in Patients With Brain Cancer Undergoing Craniotomy
Status: Active
Phase: Phase IV
Type: Supportive care, Treatment
Age: 19 and over
Trial IDs: OSU-12161, NCI-2014-01110, 2014C0007, NCT02193568
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: B1871039, NCI-2014-02251, 2013-003250-25, NCT02228382
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma
Status: Active
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933
Vismodegib in Treating Patients with Locally Advanced or Recurrent Orbital or Periocular Basal Cell Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2014.022, NCI-2015-00927, HUM00082579, ML29160, NCT02436408
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain after Surgery in Patients with Bladder Cancer
Status: Not yet active
Phase: Phase IV
Type: Health services research, Supportive care
Age: 18 and over
Trial IDs: 4B-14-4, NCI-2015-00279, NCT02438852
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 9785-MA-1008, NCI-2015-01197, NCT02441517
Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3200K1-4001, NCI-2010-01965, B2541006, NCT00672139
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Active
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299
Regadenoson Stress Echocardiogram in Detecting Coronary Artery Disease in Patients with Cancer
Status: Active
Phase: Phase IV
Type: Diagnostic
Age: 18 to 80
Trial IDs: 2013-0881, NCI-2014-01162, NCT02130453
Expanded Access Protocol of Blinatumomab in Pediatric and Adolescent Subjects With Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Status: Active
Phase: Phase IV
Type: Treatment
Age: 28 days to 17 years
Trial IDs: 20130320, NCI-2015-00115, NCT02187354
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
Status: Active
Phase: Phase IV
Type: Treatment
Age: 3 months and over
Trial IDs: B1761026, NCI-2015-00700, NCT02312037
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: STUDY00001602, NCI-2015-01331, AD-1310-08709, NCI-2015-00937, NCT02244918
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Not yet active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: ML29725, NCI-2015-01995, NCT02589717
Start Over